COLLCollegium Pharmaceutical, Inc.
Is the price fair?
Neither cheap nor expensive: nothing decisive, though modest expectations priced in.
Priced for a decline (~−20% a year). The price demands less than its three-year revenue growth of 15% a year, expectations look modest.
In its normal range: P/E 17.8 vs a 21.7 median over 19 quarters (−18% vs median).
Against the whole market›
Percentile against every name Ryufin tracks. Higher is better; the tick marks the middle of the market. Context, not one of the checks above.
Where this answer is blind. The growth-implied estimate assumes a fixed discount rate; capital-heavy sectors look structurally rich on it.
What COLL's price assumes
Collegium Pharmaceutical, Inc. trades at 17.8× earnings against 19.7× for the median Drug Manufacturers - Specialty & Generic name, cheaper than its own group.
Trailing P/E · Drug Manufacturers - Specialty & Generic median 19.7 · cheaper than the typical name in its group
- Price / sales
- 1.40
Price / sales · as of 2026-Q2
- Free cash flow yield
- 29%
Free cash flow yield · Drug Manufacturers - Specialty & Generic median 4.9%
- Growth the price implies
- −20%
Growth the price implies · The price pays for −20% free cash flow growth a year for a decade; the business has delivered +12% a year over the last three.
Details›
- Price / bookas of 2026-Q2
- 3.63
- Healthcare median P/E509 names
- 26.2
- Drug Manufacturers - Specialty & Generic median P/E45 names
- 19.7
- Free cash flow, trailing twelve months
- $328M
- Market capitalisation
- $1.13B
- 3-year revenue growth
- +15%
- 3-year free cash flow growth
- +12%
| Method | Per share |
|---|---|
| Its own P/E history, lower quartile | $19.58 |
| Its own P/E history, median | $26.95 |
| Its own P/E history, upper quartile | $33.13 |
| 52-week range | $21.85 – $49.84 |
| Today | $22.06 |
Multiples from SEC filings and end-of-day closes; implied growth from a reverse discounted cash flow. Group medians across the names Ryufin tracks.
Drug Manufacturers, Specialty & Generic
Ranks #7 of 41 by RyuScore